Immunomodulators for treatment of interstitial cystitis
- 30 April 2005
- Vol. 65 (4) , 633-638
- https://doi.org/10.1016/j.urology.2004.08.052
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- Mast cells as targets of corticotropin-releasing factor and related peptidesTrends in Pharmacological Sciences, 2004
- A Pilot Clinical Trial of Oral Pentosan Polysulfate And Oral Hydroxyzine in Patients With Interstitial CystitisJournal of Urology, 2003
- Interleukin-10 Therapy—Review of a New ApproachPharmacological Reviews, 2003
- INTRAVESICAL SODIUM HYALURONATE INHIBITS THE RAT URINARY MAST CELL MEDIATOR INCREASE TRIGGERED BY ACUTE IMMOBILIZATION STRESSJournal of Urology, 2002
- New agents for the medical treatment of interstitial cystitisExpert Opinion on Investigational Drugs, 2001
- IMPROVEMENT OF INTERSTITIAL CYSTITIS SYMPTOMS AND PROBLEMS THAT DEVELOPED DURING TREATMENT WITH ORAL IPD-1151TJournal of Urology, 2000
- Chondroitin sulphate inhibits connective tissue mast cellsBritish Journal of Pharmacology, 2000
- Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-αNature, 1996
- Anti-Inflammatory Effect of Cyclosporin A on Human Skin Mast CellsJournal of Investigative Dermatology, 1992
- Mucosal mast cellsJournal of Allergy and Clinical Immunology, 1984